Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury

Critical Care Medicine

Volumn 27, Issue 3, 1999, Pages 493-497

  Bell, Michael J ^a,b,d   Kochanek, Patrick M ^a,b   Heyes, Melvyn P ^f   Wisniewski, Stephen R ^c   Sinz, Elisabeth H ^a,b   Clark, Robert S B ^a,b   Blight, Andrew R ^e   Marion, Donald W ^g   Adelson, P David ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g NONE

Author keywords

Child abuse; Excitotoxicity; Head Injury; Head trauma; Inflammation; Macrophage; Neurotoxin; NMDA; Quinolinic acid; Shaken infant syndrome

Indexed keywords

EXCITATORY AMINO ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; QUINOLINIC ACID;

ACCIDENT; ADOLESCENT; BATTERED CHILD SYNDROME; BRAIN INJURY; CATHETER; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID DRAINAGE; CHILD; CHILDHOOD INJURY; CLINICAL ARTICLE; GAS CHROMATOGRAPHY; HUMAN; INFANT; INFLAMMATION; INTENSIVE CARE; MACROPHAGE ACTIVATION; MASS SPECTROMETRY; MORTALITY; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW;

EID: 0032906814     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199903000-00023     Document Type: Review

References (24)

1. 1. Walker M, Storrs B, Mayer T: Factors affecting the outcome in the pediatrie patient with multiple trauma: Further experience with the modified injury severity scale. Child's Brain 1984; 11: 387-397
2. 2. Kochanek PM, Marion DW, Zhang W, et al: Severe controlled cortical impact in rats: Assessment of cerebral edema, blood flow, and contusion volume. J Neurotrauma 1995; 12:1015-1025
3. 3. Faden AI, Demediuk P, Panter SS, et al: The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244:798-800
4. 4. Heyes MP, Saito K, Crowley JS, et al: Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115:1249-1273
5. 5. Heyes MP, Saito K, Milstein S, et al: Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J Neurol Sci 1995; 133:112-118
6. 6. Blight AR, Cohen TI, Saito K, et al: Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 1995; 118: 735-752
7. 7. Heyes MP, Markey SP: Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: Effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem 1988; 174: 349-359
8. 8. Rosner B: Multivariate methods in ophthalmology with application to other paired data situations. Biometrics 1984; 40:1025-1035
9. 9. Levin HS, Aldrich EF, Saydjari C, et al: Severe head injury in children: Experience of the traumatic coma data bank. Neurosurgery 1992; 31:435-444
10. 10. Palmer AM, Marion DW, Botscheller ML, et al: Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 1993; 61:2015-2024
11. 11. Lapin IP: Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: Structure-activity relationships. Neuropharmacol 1982; 21:1227-1233
12. 12. Whetsell WO, Schwarcz R: Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 1989; 97:271-275
13. 13. Guilian D, Vaca K, Corpuz M: Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 1993; 13:29-37
14. 14. Sinz EH, Kochanek PM, Heyes MP, et al: Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans. J Cereb Blood Flow Metab 1998; 18: 610-615
15. 15. Blight AR, Leroy EC, Heyes MP: Quinolinic acid accumulation in injured spinal cord: Time course, distribution, and species differences between rat and guinea pig. J Neurotrauma 1997; 14: 89-98
16. 16. Saito K, Nowak TS, Suyama K, et al: Kynurenine pathway enzymes in brain: Responses to ischemic brain injury versus systemic immune activation. J Neurochem 1993; 61:2061-2070
17. 17. Thomas SR, Mohr D, Stocker R: Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon gamma primed mononuclear phagocytes. J Biol Chem 1994; 269:14457-14464
18. 18. Hossman K-A: Glutamate-mediated injury in focal cerebral ischemia: The excitotoxin hypothesis revised. Brain Pathol 1994; 4:23-26
19. 19. Misztȧl M, Skangiel-Kramska J, Niewiadomska G, et al: Subchronic intraventricular infusion of quinolinic acid produces working memory impairment C A model of progressive excitotoxicity. Neuropharmacol 1996; 35: 449-458
20. 20. Misztal M, Frankeiwicz T, Parsons CG, et al: Learning deficits induced by chronic intraventricular infusion of quinolinic acid-protection by MK-801 and memantine. Eur J Pharmacol 1996; 296:1-8
21. 21. Susel Z, Engber TM, Kuo S, et al: Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease. Neurosci Lett 1991; 121:234-238
22. 22. Portera-Cailliau C, Price DL, Martin LJ: Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol 1997; 378:70-87
23. 23. Luerssen TG, Klauber MR, Marshall LF: Outcome from head injury related to patient's age: A longitudinal prospective study of adult and pediatric head injury. J Neurosurg 1988; 68: 409-416
24. 24. Heyes MP, Saito K, Major EO, et al: A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease. Brain 1993; 116:1425-1450